Please login to the form below

Not currently logged in
Email:
Password:

Key challenges

This page shows the latest Key challenges news and features for those working in and with pharma, biotech and healthcare.

The Harmony Alliance gathers to battle blood cancer

The alliance, which brings together 51 partners and key stakeholders from eleven European countries, uses its big data platform to better understand blood cancer and contribute to improving targeted therapies. ... Michel Van Speybroeck, director of data

Latest news

  • Sandoz says Humira biosimilar clears clinical hurdle Sandoz says Humira biosimilar clears clinical hurdle

    Patient access to often critical and expensive biologic medicines is one of the key challenges facing healthcare systems in developed economies today," said Mark Levick, Sandoz' head of biopharma development.

  • A new era of collaboration A new era of collaboration

    challenges of our age. ... This is key because, as a socially important industry, pharma businesses must proactively work to protect their licence to operate.

  • Call for closer ties between pharma and animal health Call for closer ties between pharma and animal health

    research. The public-private partnership between EFPIA and the European Union was set up to address some of the key societal and healthcare challenges. ... Human, animal and environmental health face many common or related challenges.

  • Nurturing change in pharma marketing Nurturing change in pharma marketing

    The transition through facelifts such as key account management and the deployment of field-based market access teams, has given the appearance of sales force evolution - but critics claim that much ... You need to evaluate where your product is in its

  • Crisis communications: managing the next pandemic Crisis communications: managing the next pandemic

    ensuring that the challenges your company faces as the issue unfolds and during any eventual crisis do not harm your public image. ... By understanding the predictable cycle of a crisis, your organisation can anticipate the kinds of problems and

More from news
Approximately 0 fully matching, plus 34 partially matching documents found.

Latest Intelligence

  • Creating a successful global compliance programme Creating a successful global compliance programme

    We discuss some of the key challenges in this process below and highlight a few  proposed solutions. ... Challenges faced by multinational companies. 1. Differences in the legal and regulatory environment.

  • Exploring serious market access roadblocks for rare bleeding disorders Exploring serious market access roadblocks for rare bleeding disorders

    The key challenges for patients with rare bleeding disorders are awareness, cost of care, access to care, suboptimal treatment and, critically, a dearth of published data. ... More complete data will also help pharmaceutical companies to justify drivers

  • Macron, Merkel and May: implications of the 2017 elections for the life science industry Macron, Merkel and May: implications of the 2017 elections for the life science industry

    UK Ministers recognise some of the challenges facing the life science sector but it’s not all about licensing. ... Prolonged austerity means policy continuity. Where political instability is creating an uncertain regulatory future, long-standing

  • Toward an outcome Toward an outcome

    In complex environments like the healthcare system, the ability to connect the dots and see patterns is key to being able to address challenges and develop solutions. ... Second: ramp-up relationships with providers, patients, payers and trade partners.

  • The three forces behind the re-imagining of patient care The three forces behind the re-imagining of patient care

    This has been enabled through harnessing the key forces impacting society into their planning process and could be even more powerful for pharma. ... The application of health technology to patient solutions can seem scary, but if you define the key

More from intelligence
Approximately 0 fully matching, plus 18 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Patient centricity: Reality or rhetoric?

    However, we identified 3 key challenges experienced by our clients when trying to improve patient understanding, which we will share and address in this paper.

  • Unique forum will unite NHS and industry to drive innovation

    HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare. ... It will also help industry to better understand the challenges facing the NHS by learning

  • Defining Market Access and the Key to Success

    Kevin Lennon, Head of Operations &Market Access at OUTiCO, shares his definition of market access and the key to success. ... What are the key challenges that you see companies facing? The NHS has changed drastically over the last few years and we’re

  • Pharma CI Asia Conference & Exhibition 2017

    The event is regarded as the largest assembly of pharmaceutical competitive intelligence executives in the world and brings together senior level pharma, biotech, and device professionals to learn and discuss key ... industry news and challenges.

  • Brand tracking research

    In this video Quantitative Research Directors Karen Swords and Vicky McLellan outline this and some other key challenges of conducting a successful tracking study and how to overcome them.

More from PMHub
Approximately 0 fully matching, plus 20 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics